Q2 FY2026 · ended Jun 30, 2026 · Revenue $320.11M, -17.1% YoY · Filed Aug 10, 2026
Nu Skin Enterprises, Inc. (NUS) files with the SEC under industry code 5122, Wholesale-Drugs, Proprietaries & Druggists' Sundries. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $320.1 million and a net loss of $249.8 million. Free cash flow was $5.0 million. As of Jun 30, 2026 it held $191.4 million in cash and investments and $288.1 million in total debt.
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- NUS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Provo, UT
- SEC filer status
- Accelerated filer
- SEC CIK
- 1021561
- Former names
- NU SKIN ENTERPRISES INC (until Sep 13, 2019); NU SKIN ASIA PACIFIC INC (until Aug 13, 1998); NU SKIN ASIA INC (until Sep 16, 1996)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Mckesson Corp MCK
- Cencora, Inc. COR
- Cardinal Health Inc CAH
- Herbalife Ltd. HLF
- EnerSyn Global Inc. ESYN
- Cosmos Health Inc. COSM
- DataMeds AI, Inc. MEDS
- Cellyan Biotechnology Co., Ltd HKPD
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $320.1M | $320.6M | $370.3M | $364.2M | $386.1M |
| Operating income | -$59.3M | $4.0M | $23.2M | $21.6M | $30.8M |
| Net income | -$249.8M | $1.8M | $14.5M | $17.1M | $21.1M |
| Diluted EPS | -$5.14 | $0.04 | $0.29 | $0.34 | $0.43 |
| Operating cash flow | $10.6M | -$3.9M | $16.6M | $27.5M | $35.8M |
| Free cash flow | $5.0M | -$17.6M | $5.9M | $17.6M | $35.8M |
| Total assets | $1.1B | $1.4B | $1.4B | $1.4B | $1.4B |
| Total liabilities | $578.8M | $582.7M | $600.1M | $624.6M | $655.9M |
| Stockholders' equity | $542.7M | $794.1M | $805.2M | $799.8M | $787.8M |
| Cash and investments | $191.4M | $200.4M | $244.3M | $253.0M | $265.4M |
| Total debt | $288.1M | $303.6M | $308.6M | $320.3M | $339.2M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 21, 2026 | Aug 17, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 29, 2026 | May 28, 2026 |
| 8-K |
Current report
Officer or director change
|
May 8, 2026 | May 6, 2026 |
All 1001 Nu Skin Enterprises, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.